Saturday 25 November 2017

Pfizer to buy Anacor Pharma in $5.2bn deal

Pfizer logo. Reuters/Andrew Kelly/File photo
Pfizer logo. Reuters/Andrew Kelly/File photo

Pfizer Inc will buy Anacor Pharmaceuticals Inc in a deal valued at $5.2 billion, net of cash, for access to Anacor's non-steroidal topical gel to treat eczema.

Pfizer will pay $99.25 per share for Anacor, a 55 percent premium to the stock's Friday close, the companies said on Monday.

Reuters

Promoted Links

Business Newsletter

Read the leading stories from the world of Business.

Promoted Links

Also in Business